Leap Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $634 | $0 |
Gross Profit | -5 | 524 | -107 | |
EBITDA | -21,252 | -14,825 | -14,710 | -14,833 |
EBIT | -21,454 | -14,830 | -14,820 | -14,940 |
Net Income | -20,128 | -13,820 | -12,465 | -13,696 |
Net Change In Cash | 0 | 0 | 634 | 0 |
Free Cash Flow | -13,671 | -15,516 | -10,380 | -10,488 |
Cash | 78,479 | 54,921 | 70,643 | 80,743 |
Basic Shares | 39,122 | 27,014 | 26,987 | 26,987 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $375 | $1,500 | $1,500 |
Gross Profit | -427 | -415 | 1,500 | 1,500 |
EBITDA | -86,614 | -53,787 | -40,191 | -28,215 |
EBIT | -87,041 | -54,202 | -40,747 | -28,883 |
Net Income | -81,414 | -54,596 | -40,587 | -27,514 |
Net Change In Cash | 0 | 375 | 1,500 | 1,500 |
Cost of Revenue | 62,878 | 48,065 | ||
Free Cash Flow | -43,753 | -49,044 | -35,157 | -25,957 |
Cash | 70,643 | 65,500 | 114,916 | 52,071 |
Basic Shares | 20,445 | 11,323 | 8,582 | 5,932 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.52 |
2024-03-31 | $0.51 |
2023-12-31 | -$0.46 |
2023-09-30 | -$0.51 |
